Varian Medical Systems, Inc. (NYSE:VAR) insider Dow R. Wilson sold 15,059 shares of Varian Medical Systems stock in a transaction that occurred on Thursday, September 7th. The shares were sold at an average price of $105.41, for a total transaction of $1,587,369.19. Following the completion of the transaction, the insider now directly owns 81,835 shares in the company, valued at $8,626,227.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Shares of Varian Medical Systems, Inc. (NYSE:VAR) traded up 1.06% during trading on Friday, hitting $106.42. 584,041 shares of the stock were exchanged. Varian Medical Systems, Inc. has a 52 week low of $75.20 and a 52 week high of $107.19. The firm has a market capitalization of $9.77 billion, a price-to-earnings ratio of 35.03 and a beta of 0.58. The stock’s 50 day moving average price is $100.89 and its 200 day moving average price is $96.47.

Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.09. The business had revenue of $662.40 million during the quarter, compared to analysts’ expectations of $663.86 million. Varian Medical Systems had a net margin of 9.50% and a return on equity of 24.70%. The firm’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.00 EPS. On average, equities analysts predict that Varian Medical Systems, Inc. will post $3.93 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Dow R. Wilson Sells 15,059 Shares of Varian Medical Systems, Inc. (VAR) Stock” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this report on another site, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.americanbankingnews.com/2017/09/08/dow-r-wilson-sells-15059-shares-of-varian-medical-systems-inc-var-stock.html.

A number of institutional investors and hedge funds have recently made changes to their positions in VAR. BlackRock Inc. boosted its position in Varian Medical Systems by 3,169.5% during the 1st quarter. BlackRock Inc. now owns 7,899,768 shares of the medical equipment provider’s stock valued at $719,907,000 after buying an additional 7,658,148 shares during the period. Janus Henderson Group PLC lifted its position in shares of Varian Medical Systems by 1,545.7% in the 2nd quarter. Janus Henderson Group PLC now owns 3,754,727 shares of the medical equipment provider’s stock worth $387,450,000 after purchasing an additional 3,526,571 shares during the period. Koch Industries Inc. lifted its position in shares of Varian Medical Systems by 57,988.4% in the 2nd quarter. Koch Industries Inc. now owns 1,327,901 shares of the medical equipment provider’s stock worth $1,315,000 after purchasing an additional 1,325,615 shares during the period. FMR LLC lifted its position in shares of Varian Medical Systems by 324.5% in the 1st quarter. FMR LLC now owns 1,006,924 shares of the medical equipment provider’s stock worth $91,760,000 after purchasing an additional 769,718 shares during the period. Finally, Arrowstreet Capital Limited Partnership purchased a new stake in shares of Varian Medical Systems in the 2nd quarter worth about $77,323,000. 99.64% of the stock is owned by institutional investors and hedge funds.

VAR has been the topic of a number of recent analyst reports. Goldman Sachs Group, Inc. (The) initiated coverage on shares of Varian Medical Systems in a research note on Tuesday, May 16th. They issued a “neutral” rating and a $92.00 price objective on the stock. Zacks Investment Research raised shares of Varian Medical Systems from a “hold” rating to a “buy” rating and set a $117.00 price objective on the stock in a research note on Tuesday, June 27th. Citigroup Inc. raised shares of Varian Medical Systems from a “neutral” rating to a “buy” rating in a research note on Monday, May 15th. Robert W. Baird reissued a “neutral” rating and issued a $99.00 price objective (up from $89.00) on shares of Varian Medical Systems in a research note on Friday, July 14th. Finally, Aegis reissued a “hold” rating and issued a $91.00 price objective on shares of Varian Medical Systems in a research note on Wednesday, May 17th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $97.39.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.